Areas of Focus

• Development of innovative approaches in quantitative mass spectrometry-based proteomics
• Investigation of the onset, progression, diagnosis, and treatment of cancer with unprecedented molecular-level detail.
• Identifying predictive biomarkers for early-stage diagnosis of cancer
• Diagnostic and biological significance of several novel candidate markers in human ovarian cancer cells, plasma, and tumors
• Identifying molecular signatures that can stratify lung cancer patients for the development of personalized therapeutic strategies
• Expand the use of SILAC as a quantitative approach toward clinical specimens.

VCU School of Pharmacy directory profile